Cancer Immunotherapy Market - Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
Global
Cancer Immunotherapy Market: Overview
The
growing incidences of cancer and a need to treat them is the key
driver of the global immunotherapy market. The number of deaths
occurring due to cancer is increasing every year and has therefore
forced government bodies to take initiatives for the improvement of
the health conditions of people, by investing heavily in research and
development and enabling innovation and advancements in technology so
as to offer improved treatments. This has pushed the growth of the
global cancer immunotherapy therapy. As immunotherapy therapy has a
higher success rate and proven efficiency over conventional treatment
methods for cancer, its demand is higher and therefore, the market is
expected to witness a remarkable growth over the coming years. The
treatment pipeline looks promising and is thus, expected to ensure a
healthy growth of the market.
The
report offers forecasts of the overall cancer immunotherapy market
over the global level as well as on regional levels. The estimated
size of each of the segments and sub-segments has also been given in
the report. Macroeconomic indicators, drivers, and restraints
impacting the global cancer immunotherapy market have been included
along with their impact on each region. Current challenges met by
players in the cancer immunotherapy market have been elaborated on,
thus giving a brief idea to readers and investors the problems they
may encounter while investing in the competitive market.
Global
Cancer Immunotherapy Market: Trends and Drivers
The
global cancer immunotherapy market is expected to hold promising
growth as there lies immense scope for improvement and development.
The increasing number of clinical trials held particularly in
immunotherapy is expected to boost the market’s growth. With the
recognition from various medical bodies as the foremost line of
therapy over conventional chemotherapy, cancer immunotherapy is
estimated to hold immense potential and growth opportunity in the
coming years.
However,
factors such as high attrition rates during product development phase
are anticipated to restrict the growth of the market. Also, an
overall lack of awareness about immunotherapy being a better
treatment option will impede the growth of the market. The high cost
of clinical trials poses a challenge for players in the market. With
many types and subtypes of cancer, having a single mode of treatment
method is impossible, increasing the attrition rates of new drugs and
treatments. Only a handful of contenders in the pipeline pass through
the phase III trials and the rest are considered to be inefficient.
This is yet another challenge faced by players in the market.
View
Report @ http://www.marketresearchreports.biz/analysis/910648
Global
Cancer Immunotherapy Market: Segmentation
On
the basis of therapeutic area, the market is segmented into
colorectal cancer, lung cancer, breast cancer, melanoma, prostate
cancer, and blood cancer. By end users, the global cancer
immunotherapy market is segmented into ASC’s (ambulatory surgical
centers), hospitals, clinics, and cancer research centers. Hospitals
are expected to be the leading segment in the market. On the basis of
region, the market is segmented into North America, Europe,
Asia-Pacific, Latin America and the Middle East and Africa. Asia
Pacific is poised to witness significant growth in the market.
Key
Players Mentioned in this Report are:
The
report provides studies key players operating in the market. Some of
the key players in the global cancer immunotherapy market are:
F.Hoffmann-La Roche Ltd., AstraZenca Plc, Eli Lilly and Company,
Amgen, Inc., Bristol-Myers Squibb Company, GlaxoSmithKline Plc.,
Novartis AG, Pfizer, Inc., Janssen Biotech, Inc., Merck & Co.,
Inc., Janssen Biotech, Inc., Merck & Co., Inc., Sanofi, Takeda
Pharmaceuticals, and Spectrum Pharmaceuticals, Inc.
Get
Sample Copy of this report @
http://www.marketresearchreports.biz/sample/sample/910648
The
report segments the global cancer immunotherapy market as:
By
Geography:
North America
Asia Pacific
Europe
Rest of the World
This
report gives you access to decisive data such as:
Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for the coming
years
Key
highlights of this report
Overview of key market forces
propelling and restraining market growth
Up-to-date analyses of market
trends and technological improvements
Pin-point analyses of market
competition dynamics to offer you a competitive edge
An analysis of strategies of major
competitors
An array of graphics and SWOT
analysis of major industry segments
Detailed analyses of industry
trends
A well-defined technological
growth map with an impact-analysis
Offers a clear understanding of
the competitive landscape and key product segments
Table
of Content
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Cancer
Immunotherapy Market
4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Key Market Indicators
4.3.1. Region/Country Specific
4.3.2. Product/Therapeutic Area Specific
4.3.3. Target Market Specific – Global
Scenario
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunity
4.4.4. Trends
4.5. Global Cancer Immunotherapy Market
Analysis and Forecasts, 2016–2024
4.5.1. Market Revenue Projections (US$
Mn)
4.6. Cancer Immunotherapy Market - Global
Supply Demand Scenario
4.7. Porter’s Five Force Analysis
4.8. Value Chain Analysis
4.8.1. List of active market participants
4.8.1.1. Manufacturers
4.8.1.2. Distributors
4.8.2. Forward – Backward Integration
Scenario
4.9. Market Outlook
4.10. Pipeline Snapshot
4.11. Cancer Epidemiology
4.12. Reimbursement Scenario and Patient
Support Programs Overview
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
Comments
Post a Comment